Alzheimer's Society says women should not be alarmed over small hormone therapy risk.

Diagnosing Lyme disease if bull’s eye rash is present – NICE quality standard

Doctors should be diagnosing Lyme disease if bull’s eye rash is present, says NICE as it launches its Lyme disease NICE quality standard consultation. The...
The Topol Review and innovative technologies in the NHS

The Topol Review: Preparing the healthcare workforce to deliver the digital future

The Topol Review: Preparing the healthcare workforce to deliver the digital future has been published and it makes recommendations to enable NHS staff to...
Research into chemotherapy dose intensity and breast cancer

Research into chemotherapy dose intensity and breast cancer

New research into chemotherapy dose intensity and breast cancer finds that giving chemotherapy drugs every two weeks instead of the usual every three weeks...
bottles of medicine affordable and innovative medicines

Competition enforcement contributes to affordable and innovative medicines

The European Commission has published a report showing that active competition law enforcement, at EU and national level, in the pharmaceutical sector contributes to...
Brain image depositing the origins of depression

Origins of depression brought into focus in large-scale gene study

The origins of depression have been brought into focus in a large-scale gene study, involving more than two million people. Hundreds of genes have been newly-linked...
Call for female healthcare scientists to apply for NHS England leadership scheme

Mapping oesophageal cancer genes leads to new drug targets

Mutations that cause oesophageal adenocarcinoma (OAC) have been mapped in unprecedented detail – unveiling that many could be targeted by drugs currently in trials...
new GP contract

Response to new GP contract

With the announcement of the new GP contract negotiated by the BMA and NHS England, there has been a slew of responses. Professor Helen Stokes-Lampard,...
Smart Peak Flow - an asthma monitoring device

Smart Peak Flow detects asthma exacerbations before patients feel it

Smart Peak Flow - the medically certified asthma monitoring device that plugs into a the headphone jack of a smartphone.  The World Health Organisation estimates...
Man looking at sign showing cross roads for NHS commissioning

Is pharma prepared for future NHS commissioning?

What’s the future for NHS commissioning and is pharma prepared? The NHS has had commissioning since 1991 but it has definitely failed to thrive and,...
Bristol-Myers Squibb-Pfizer Alliance announces results from Phase 4 AUGUSTUS trial.

NHS App begins public rollout

After successful private testing with more than 3,000 patients across 30 GP practices in England, the NHS App has started its public rollout. The NHS...

Latest articles

Investigational therapy has potential to become first oral GLP-1 receptor agonist for those living with type 2 diabetes

Novo Nordisk presents oral semaglitude data at ENDO

Oral semaglutide 7 mg and 14 mg doses showed superior reductions in blood sugar and weight compared to sitagliptin at 26 weeks in data...
Pf Award Winners

Pf Award Winners on the positive patient outcomes that come from working together

The winners of the Joint Working Pf Award 2018, Senior Coloplast Care Nurse Ruth Christer and NHS Partnership Manager, Coloplast, Jonathan Walker, on the...
Brain scan image: Detecting and managing atrial fibrillation

Detecting and managing atrial fibrillation

The ‘Podiatry and Atrial Fibrillation – Save a life, stop a stroke’ webinar was created to improve the detection and management of atrial fibrillation,...

Popular articles

Brain scan image: Detecting and managing atrial fibrillation

Detecting and managing atrial fibrillation

The ‘Podiatry and Atrial Fibrillation – Save a life, stop a stroke’ webinar was created to improve the detection and management of atrial fibrillation,...
Samsung Bioepis Announces Three-year Follow-up Data for Biosimilar ONTRUZANT® (trastuzumab) in Early or Locally Advanced HER2-positive Breast Cancer

Samsung Bioepis announces three-year follow-up data for biosimilar ONTRUZANT® (trastuzumab)

Samsung Bioepis announces three-year follow-up data for biosimilar ONTRUZANT® (trastuzumab) in early or locally advanced HER2-positive breast cancer. Samsung Bioepis has announced the findings of...
The future of genomics

The future of genomics and precision medicine

How is the use of genomics data enhancing our medical understanding and what does this mean for the future of precision medicine? Genomics is one of...
Investigational therapy has potential to become first oral GLP-1 receptor agonist for those living with type 2 diabetes

Novo Nordisk presents oral semaglitude data at ENDO

Oral semaglutide 7 mg and 14 mg doses showed superior reductions in blood sugar and weight compared to sitagliptin at 26 weeks in data...
Image of graduates: skills shortage in life sciences

Addressing the skills shortage in life sciences

How can collaboration help to fill the skills shortage gap to ensure that the UK can compete in the global future of life sciences? The...